Evoke Pharma Inc (EVOK)
Latest EVOK Insider Trades
About Evoke Pharma Inc (EVOK)
Evoke Pharma Inc files with the SEC under CIK 0001403708 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
90-Day SEC Filing Activity
No Form 4 activity for EVOK in the last 90 days.
EVOK Insider Transactions (Form 4)
3614 Form 4 filings on record, the earliest from Oct 22, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Greg Pyszczymuka | Derivative | Stock Option (Right to Buy) | 5,833 | - |
EVOK Insider Trading - FAQ
What is the latest insider trade for EVOK?
Evoke Pharma Inc (EVOK) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-12-17. The full record for EVOK runs to 14 Form 4 filings, the earliest from 2024-10-22. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying EVOK stock?
No insider purchases of EVOK were filed in the last 90 days.
How many insiders are selling EVOK stock?
No insider sales of EVOK were filed in the last 90 days. 2 sales are on record for this company.
Where can I see EVOK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks EVOK Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow EVOK insider buys?
Create a free InsiderAlpha account and press Watch on this page to add EVOK to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Greg Pyszczymuka view on EDGAR
- - Benjamin C. Smeal view on EDGAR
- - Marilyn R. Carlson view on EDGAR
- - Cam L. Garner view on EDGAR
- - Malcolm R. Hill view on EDGAR
- - Mark Kowieski view on EDGAR
- - Kenneth J. Widder view on EDGAR
- - Todd C. Brady view on EDGAR
- - Vickie S. Reed view on EDGAR
- - Matthew J. D'Onofrio view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where EVOK's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track EVOK insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
